AzTrials
AzTrials

Orthopedic Disorder of SpineNCT03959059

PKP Assisted With MR Technology in OVCF With IVC

A study testing Mixed Reality technology in people with Orthopedic Disorder of Spine, run by Nanjing First Hospital, Nanjing Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To prospectively assess the outcome of PKP assisted with and without MR technology in treatment of OVCF with IVC. Read more about this study

Who is it for?
Ages 50 to 95 years
Conditions the study is for
Orthopedic Disorder of Spine
What is being tested?
Mixed Reality technology
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteChina
Study dates
15 Jun 2017to 20 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 95 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Single level OVCF in the thoracic and lumbar levels (T10-L4), suffering with severe back pain.;
  • OVCF without damaged vertebral posterior wall and nerve lesion;
  • The patient was over 50 years old and , the diagnosis of osteopenia or osteoporosis was confirmed by bone densitometry ;
  • All patients underwent(received) plain radiography, computed tomography (CT) and MRI before surgery, and with IVC presented in MRI.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

China1 site
  • Mixed Reality

    Nanjing, Jiangsu, 210029

Other trials in China

About this study

Official title: Percutaneous Kyphoplasty Assisted With/Without Mixed Reality Technology in Treatment of OVCF With IVC: a Prospective Study

To prospectively assess the outcome of PKP assisted with and without MR technology in treatment of OVCF with IVC.

Read the detailed description

The study is to prospectively assess the outcome of PKP assisted with and without MR technology in treatment of OVCF with IVC. Forty cases of OVCF with IVC undergoing PKP were randomized into a MR technology assisted group (group A) and a traditional C-arm fluoroscopy group (group B). Both groups were performed PKP and evaluated by VAS scores, ODI scores, radiological evidence of vertebral body height and kyphotic angle(KA) at pre-operation and post-operation. The volume of injected cement and Operation time was recorded. And whether cement touching both endplates or not(non-PMMA-endplates-contact, NPEC) in radiological evidence were also recorded postoperatively. The clinical outcomes and complications were evaluated afterwards. All patients received 10 to 14 months' follow-up, with an average of 12 months.

Being tested
Mixed Reality technology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mixed Reality technologyDevice

    combine image with real body

Study groups in NCT03959059
Study groupRoleWhat they receive
PKP of traditional procedureExperimentaltraditional method of PKP
Receives: Device: Mixed Reality technology

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. visual analog scale

    visual analog scale(0-10 scores) is for pain, 0 represent no pain, 10 score represent the severe pain.

    Measured: 1 year

  2. Oswestry Disability Index

    Oswestry Disability Index is for movement function, Questionnaire examines perceived level of disability in everyday activities of daily living. The ODI score (index) is calculated as: For example: If all 10 sections are completed, the score is calculated as follows: if 16 (total scored) out of 50 (total possible score) x 100 = 32%; If one section is missed (or not applicable), the score is calculated: If 16 (total scored) / 45 (total possible score) x 100 = 35.5%.

    Measured: 1 year

  3. Vertebral height

    Vertebral height in X-ray is for recontruction of the vertebra.

    Measured: 1 year

  4. Kyphotic angle

    kyphotic angle in X-ray is also for recontruction of the vertebra.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2019
  2. Study start15 Jun 2017
  3. Primary completion30 Sep 2017
  4. Study completion20 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03959059
Sponsor's protocol ID
KY20160122-47
Status last verified
May 2019
First submitted
10 May 2019
Last updated
22 May 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Wei P, Yao Q, Xu Y, Zhang H, Gu Y, Wang L. Percutaneous kyphoplasty assisted with/without mixed reality technology in treatment of OVCF with IVC: a prospective study. J Orthop Surg Res. 2019 Aug 8;14(1):255. doi: 10.1186/s13018-019-1303-x.

    PubMed 31395071

Questions about this trial

What is this clinical trial studying?

A study testing Mixed Reality technology in people with Orthopedic Disorder of Spine, run by Nanjing First Hospital, Nanjing Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

visual analog scale (time frame: 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03959059, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in